WebMar 18, 2024 · Trillium Therapeutics Inc (Trillium), formerly Neurogenesis Biotech Corp, a subsidiary of Pfizer Inc, is a clinical-stage immuno-oncology company, which develops … WebProducts of Trillium Therapeutics. Product portfolio. biopharmaceuticals . Find other companies; Show 1 more products of Trillium Therapeutics Show less. News about …
TRIL Stock Forecast, Price & News (Trillium Therapeutics) - MarketBeat
WebMar 1, 2024 · Trillium Therapeutics Inc. is a clinical stage immuno-oncology company. The Company develops therapies for the treatment of cancer and has preclinical programs, … WebApr 29, 2024 · Trillium Therapeutics is a pharmaceutical company with massive upside potential for its innovative cancer treatment therapies. ... It owns and controls patent … movement type 453 in sap
Regulus Therapeutics (NASDAQ:RGLS) Stock Price Crosses Below …
WebAug 23, 2024 · Under the terms of the agreement, Pfizer will acquire all outstanding shares of Trillium not already owned by Pfizer for an implied equity value of $2.26 billion, or $18.50 per share, in cash ... WebAug 23, 2024 · Aug 23 (Reuters) - Pfizer Inc said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc in a $2.26 billion deal to strengthen its arsenal of … WebApr 28, 2024 · Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance … heaters at game store